SCHEMBL4798511

SCHEMBL4798511

Clc1nc(SCc2ccccc2Cl)ns1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.58
MAPT P10636 4/20 0.50
HPGD P15428 4/20 0.49
GAA P10253 4/20 0.49
L3MBTL1 Q9Y468 4/20 0.49
LMNA P02545 2/20 0.49
RECQL P46063 2/20 0.49
KDM4E B2RXH2 1/20 0.49
MEN1 O00255 1/20 0.49
ALDH1A1 P00352 1/20 0.49
PLA2G1B P04054 1/20 0.49
POLB P06746 1/20 0.49
ALOX12 P18054 1/20 0.49
PTPN7 P35236 1/20 0.49
DUSP3 P51452 1/20 0.49
BLM P54132 1/20 0.49
ATG4B Q9Y4P1 1/20 0.49
MGAM O43451 1/20 0.49
SI P14410 1/20 0.49
MGAM2 Q2M2H8 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4797641 0.80 RAB9A (0.66) KMT2AMAPTHPGDL3MBTL1RECQL
SCHEMBL4798493 0.73 L3MBTL1 (0.59) KMT2AMAPTGAAL3MBTL1LMNA
SCHEMBL4797136 0.73 MAPT (0.49) KMT2AMAPTGAAL3MBTL1LMNA
SCHEMBL21338153 0.72 HPGD (0.71) KMT2AHPGDGAAL3MBTL1LMNA
SCHEMBL4798776 0.72 TOP2A (0.49) KMT2AMAPTHPGDL3MBTL1LMNA
SCHEMBL4797109 0.71 RAB9A (0.51) KMT2AMAPTHPGDGAAL3MBTL1
SCHEMBL4795272 0.70 MAPT (0.42) KMT2AMAPTGAAL3MBTL1LMNA
Acetic Acid SCHEMBL27339379 0.70 RAB9A (0.52) MAPTL3MBTL1LMNAKDM4EALDH1A1
SCHEMBL5309782 0.69 HPGD (0.67) KMT2AHPGDGAAL3MBTL1LMNA
SCHEMBL5310304 0.69 KMT2A (0.69) KMT2AMAPTHPGDGAAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7342031-B2 Thiadiazole compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2008-03-11 US disclosed
US-7342031-B2 Thiadiazole compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2008-03-11 US disclosed
US-7342031-B2 Thiadiazole compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2008-03-11 US disclosed
US-20060014962-A1 Thiadiazole compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-01-19 US disclosed
EP-1550661-A1 THIADIAZOLE COMPOUND AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2005-07-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060014962-A1 Thiadiazole compound and use thereof CBR3, TH, CYP2E1 KMT2A 3843/4885MAPT 3930/4885HPGD 2693/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.